NTAG215
Ordinary NFC for information access
NTAG215 can open approved product and batch information through a static link. Keep patient-facing content under approval and do not present a registered-page lookup as authentication of a medicine.
// Industries
NFC product information and verification for medicines
HASHENTIC / NFC09
Potential label placementPackaging seal
A pharmaceutical NFC touchpoint can connect packaging to approved product information and a controlled record. Its role must be defined alongside the required identification, safety and dispensing processes.
Choose the NFC tag for your product
Agree the NFC label’s role with packaging and quality specialists. It may provide approved information or tag evidence alongside, rather than replacing, required pharmaceutical identification and verification processes.
Tag specifications and placement guidance
NTAG424 DNA / EM4425
Secure NFC for tag verification
Correctly configured NTAG424 DNA or EM4425 can support backend cryptographic tag checks. This does not independently prove safe contents, an unopened pack or completion of required repository checks.
Carrier design near metal
Blister foil, metallic print and metal containers may need adapted positioning or an appropriate on-metal carrier. Validate this construction separately from the chip’s cryptographic function with the packaging team.
Packaging and operating limits
Test the final pack under intended production, processing and storage conditions. Do not obscure mandatory text; changes to seals, tamper evidence and regulated workflows require their own assessment and validation.
From approved packaging to controlled information
- 01
Validate the packaging change
Review placement with packaging and quality teams, then test the final pack without obscuring required markings.
- 02
Link approved information
Define product and batch association and content approval; demonstrate the tag check without implying proof of safe contents.
- 03
Rehearse quality exceptions
Agree handling of wrong associations, damaged seals and recall notices alongside the applicable regulated verification processes.
Protect the existing packaging controls
Evaluate a label on the carton or a suitable seal with packaging and quality specialists. Test foil blisters, metallic decoration, storage conditions and the final pack. Do not obscure mandatory text or assume that adding an inlay preserves an existing tamper-evident design without validation.
Keep information under approval
Associate product and batch identifiers with approved information. Define how updates, withdrawals and corrections are authorised and how an incorrect tag association is contained. Keep patient-facing information separate from restricted operational records and avoid collecting unnecessary personal data.
Explain what the tag proves
A configured secure NFC chip can support cryptographic verification of a tag. Ordinary NTAG424 DNA verification does not establish that a package has never been opened, or that its contents are authentic or safe.
Required serialization, repository checks and dispensing controls need their own validated implementation. NFC should not be presented as a substitute for applicable pharmaceutical verification systems or professional advice.
Pilot with quality and operations teams
Choose one packaging configuration and define reading, label application and reconciliation criteria. Include a damaged seal, wrong batch association, recall notice and unreadable tag. Assess any integration and regulatory requirements before extending the workflow into production or patient use.
// Industries
NFC pilot for pharmaceutical packaging
Describe your product, packaging material, intended scan or verification result, target market and expected pilot scope. The team can then assess placement, data and integration requirements.
All industries